Featured Research

from universities, journals, and other organizations

Mayo Clinic Researchers Discover That Donor Kidney Protects Itself In New Body

Date:
August 26, 2003
Source:
Mayo Clinic
Summary:
A long-standing medical discussion about how transplanted organs survive in a new body has received provocative new evidence from Mayo Clinic research. It shows a donated kidney survives in a new body by turning on a protective mechanism to shield it from the hostile environment of the patient's immune system.

ROCHESTER, Minn. -- A long-standing medical discussion about how transplanted organs survive in a new body has received provocative new evidence from Mayo Clinic research. It shows a donated kidney survives in a new body by turning on a protective mechanism to shield it from the hostile environment of the patient's immune system. The results are published in this month's American Journal of Transplantation.

Says Mark Stegall, M.D., head of the transplant team that studied kidney genes' response to transplantation, "The big question has always been: Why don't the antibodies injure the kidney? Our study begins to show one possible reason for that -- there's a protective mechanism at work."

In the study, the Mayo Clinic team analyzed which genes are turned on during the biological phenomenon known as "accommodation" -- the process by which a transplanted organ adapts to the new environment of the donor's body. Accommodation was first described 20 years ago by Jeffrey Platt, M.D., a Mayo Clinic transplant biologist and co-author of this current Mayo Clinic study.

James Gloor, M.D., a Mayo Clinic nephrologist and research team member, describes the significance of the work this way: "It's not that the recipient's immune system fails to see the organ; it's more that the organ, in some way, can turn on this protection that allows it to inhabit this otherwise hostile environment of a new body."

An Accommodation Analogy: Calluses and Blisters

Transplant surgeons want to get to the heart of the accommodation mechanism so they can manipulate it most effectively and gently. Their goal is to provide the patient maximum benefit in a transplant with the least side effects.

Says Dr. Gloor, "In biology, most of the time the body can protect itself from a variety of things." He offers the example of how feet protect themselves from the friction of new shoes that cause blisters by producing protective skin thickenings: calluses. "Once your feet have calluses, you can walk around with your shoes and you don't develop blisters anymore. The reason you can is that your foot has accommodated to that hostile environment," he says.

Drs. Stegall and Gloor say a similar protective response appears to occur during kidney transplantation. For example, when one kidney is removed from the donor, that leaves the donor with a single functioning kidney which senses that it needs to do more work. "We can see it will get bigger so it can do more work. It's compensating for the fact that it's the only one there,'' Dr. Gloor explains.

The Experiment

To try to observe the mechanisms at work in accommodation, the Mayo Clinic team used a molecular biological technique that allowed them to look at which genes were expressed in kidney transplants in which the donor's and patient's immune systems were compatible. They then contrasted the compatible-transplant gene expression patterns with genes expressed in kidney transplants that were immunologically incompatible.

The Results

Different gene-expression patterns occurred in different situations. Says Dr. Stegall, "We found that there was a wide array of entirely different genes turned on -- or turned off -- in the incompatible transplants that were not changed in regular kidney transplants. It implies that something is happening in the incompatible kidney. From the results, it seems likely that the kidney is 'accommodating' to the otherwise destructive antibodies by developing processes that actually protect it." Accommodation, he adds, may actually be a fairly general phenomenon present in a variety of human diseases.


Story Source:

The above story is based on materials provided by Mayo Clinic. Note: Materials may be edited for content and length.


Cite This Page:

Mayo Clinic. "Mayo Clinic Researchers Discover That Donor Kidney Protects Itself In New Body." ScienceDaily. ScienceDaily, 26 August 2003. <www.sciencedaily.com/releases/2003/08/030826070244.htm>.
Mayo Clinic. (2003, August 26). Mayo Clinic Researchers Discover That Donor Kidney Protects Itself In New Body. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2003/08/030826070244.htm
Mayo Clinic. "Mayo Clinic Researchers Discover That Donor Kidney Protects Itself In New Body." ScienceDaily. www.sciencedaily.com/releases/2003/08/030826070244.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins